Obesity and Cardiometabolic Syndrome in Children
Overview
Pharmacology
Affiliations
The cardiometabolic syndrome is highly prevalent among overweight youth. The risk of developing the cardiometabolic syndrome is likely triggered or exacerbated by concurrent obesity, unhealthy lifestyle/eating habits, and hormonal changes (puberty). Current screening recommendations include measurement of blood pressure, fasting insulin and glucose, and total cholesterol. However, limiting assessments to these measures underestimates cardiometabolic risk in overweight youth, particularly minorities. Early identification of cardiometabolic risk in its incipient stages may justify early and more aggressive intervention to prevent progression and complications. This review provides rationale for additional assessments to determine cardiometabolic risk in overweight youth and recommends treatment options.
Kopecky M, Rimarova K, Dorko E, Kikalova K, Miskarova S, Tejova M Cent Eur J Public Health. 2025; 32(Supplement):42-51.
PMID: 39832147 DOI: 10.21101/cejph.a8283.
Velasquez-Mieyer P, Nieto-Martinez R, Velasquez A, Mou X, Young-Moss S, Mechanick J Nutrients. 2024; 16(18).
PMID: 39339743 PMC: 11434753. DOI: 10.3390/nu16183143.
Velasquez-Mieyer P, Nieto-Martinez R, Neira C, De Oliveira-Gomes D, Velasquez Rodriguez A, Ugel E Nutrients. 2024; 16(5).
PMID: 38474830 PMC: 10934978. DOI: 10.3390/nu16050703.
Prevalence of arterial hypertension in pediatric hospitalized patients.
Chacon-Jaimes D, Morales-Contreras C, Abad J, Nino-Serna L, Velez-Echeverri C Arch Cardiol Mex. 2023; 93(1):13-21.
PMID: 36757775 PMC: 10161844. DOI: 10.24875/ACM.21000362.
Hasan M, Mohieldein A, Almutairi F Int J Health Sci (Qassim). 2017; 11(3):33-37.
PMID: 28936149 PMC: 5604276.